Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

KNG1 anticorps (AA 2-110) (Biotin)

Cet anticorps Lapin Polyclonal détecte spécifiquement KNG1 dans ELISA. Il présente une réactivité envers Rat.
N° du produit ABIN7178918

Aperçu rapide pour KNG1 anticorps (AA 2-110) (Biotin) (ABIN7178918)

Antigène

Voir toutes KNG1 Anticorps
KNG1 (Kininogen 1 (KNG1))

Reactivité

  • 59
  • 11
  • 8
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Rat

Hôte

  • 62
  • 9
  • 4
Lapin

Clonalité

  • 68
  • 7
Polyclonal

Conjugué

  • 53
  • 5
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp KNG1 est conjugé à/à la Biotin

Application

  • 54
  • 33
  • 32
  • 13
  • 11
  • 8
  • 6
  • 6
  • 4
  • 2
  • 1
  • 1
  • 1
ELISA
  • Épitope

    • 6
    • 6
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 2-110

    Fonction

    Kng1 Antibody, Biotin conjugated

     Réactivité croisée

    Rat

    Purification

    Protein G purified

    Pureté

    >95 %

    Immunogène

    Recombinant Rat Kininogen-1 protein (2-110AA)

    Isotype

    IgG
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    KNG1 (Kininogen 1 (KNG1))

    Autre désignation

    Kng1

    Sujet

    Background: Kininogens are inhibitors of thiol proteases, (2) HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII, (3) HMW-kininogen inhibits the thrombin- and plasmin-induced aggregation of thrombocytes, (4) the active peptide bradykinin that is released from HMW-kininogen shows a variety of physiological effects: (4A) influence in smooth muscle contraction, (4B) induction of hypotension, (4C) natriuresis and diuresis, (4D) decrease in blood glucose level, (4E) it is a mediator of inflammation and causes (4E1) increase in vascular permeability, (4E2) stimulation of nociceptors (4E3) release of other mediators of inflammation (e.g. prostaglandins), (4F) it has a cardioprotective effect (directly via bradykinin action, indirectly via endothelium-derived relaxing factor action), (5) LMW-kininogen inhibits the aggregation of thrombocytes, (6) LMW-kininogen is in contrast to HMW-kininogen not involved in blood clotting.

    Aliases: Kng1 antibody, Kng antibody, Kininogen-1 [Cleaved into: Kininogen-1 heavy chain, Bradykinin, Kininogen-1 light chain] antibody

    UniProt

    P08934

    Pathways

    ACE Inhibitor Pathway, Glycosaminoglycan Metabolic Process
Vous êtes ici:
Chat with us!